BUY Torrent Pharmaceuticals Limited — Macquarie
byMacquarieHorizon: NA (inferred 1 year)31 Jul 2026via NDTV Profit (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Torrent Pharmaceuticals Q1 Results: Profit rises 3% to Rs 566 crore
NewsEt-Markets·30 Jul · today
Torrent Pharma Q1 Results: India, US growth lifts revenue 55%, margin expands
NewsCnbc-Tv18·30 Jul · today
1 other SEBI-registered advisor has an active long-term BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·31 Jul · today
The company has received final listing and trading approval for equity shares issued and allotted under a Scheme of Amalgamation.
BSE · Company Update·27 Jul · 3d ago
Torrent Pharmaceuticals Ltd has received a certified copy of the final order from NCLT sanctioning the amalgamation scheme of J.B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals.
BSE · Company Update·7 Jul · 3w ago
Torrent Pharma is voluntarily recalling select batches of Semalix injection disposable pens due to a product recall notification from its manufacturer, Dr. Reddy's Laboratories, for technical evaluati
NSE · Press Release·9 Jul · 3w ago
Torrent Pharma is voluntarily recalling select batches of Semalix injection disposable pens due to a product recall notification from its manufacturer, Dr. Reddy's Laboratories, for technical evaluati
BSE · Company Update·9 Jul · 3w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Torrent Pharmaceuticals
- BUY — Manas Jaiswal23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY — Prakash Gaba19 Oct 2026 · Same day · target ₹4,680 · SL hit
- SELL — Prakash Gaba7 Oct 2026 · Next day · target ₹4,650 · SL hit
- BUY — HSBC Securities7 Oct 2026 · ~1 year · target ₹5,680 · Active
- BUY — Shrikant Chouhan, Kotak Securities29 Sept 2026 · ~3 months · target ₹5,100 · Active
More from Macquarie
- BUY The Indian Hotels Company22 Oct 2026 · ~1 year · target ₹860 · Active
- BUY Oil and Natural Gas Corporation15 Oct 2026 · ~1 year · target ₹260 · Active
- BUY Hitachi Energy India12 Oct 2026 · ~1 year · target ₹38,500 · Active
- BUY Titan Company7 Oct 2026 · ~1 year · target ₹5,600 · Active
- SELL Mankind Pharma7 Oct 2026 · ~1 year · target ₹2,200 · Active

